AdaptHealth Overview
AdaptHealth Target Price
Where could AHCO trade next? Consensus target price: $11.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.64
Average Target Price
$10.50
86.2% upside
86.2% upside8 analysts in the last 4 months
High: $15 | Low: $8
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-17 | Robert W. Baird | $9 | 59.6% upside |  |
| 2026-08-06 | UBSKevin Caliendo | $10 | 77.3% upside | |
| 2026-08-06 | RBC Capital | $8 | 41.8% upside | |
| 2026-08-05 | Truist Financial | $9 | 59.6% upside | |
| 2026-08-05 | Robert W. BairdEric Coldwell | $10 | 77.3% upside | |
| 2026-08-05 | Canaccord Genuity | $10 | 77.3% upside | |
| 2026-07-21 | JefferiesBrian Tanquilut | $13 | 130.5% upside | |
| 2026-07-06 | Robert W. Baird | $15 | 166% upside | |
| 2026-05-11 | RBC Capital | $15 | 166% upside | |
| 2026-05-06 | Canaccord Genuity | $16 | 183.7% upside | |
| 2026-05-06 | Robert W. BairdEric Coldwell | $18 | 219.1% upside | |
| 2026-04-20 | JefferiesBrian Tanquilut | $11 | 95% upside | |
| 2026-02-26 | Leerink PartnersWhit Mayo | $12 | 112.8% upside | |
| 2026-02-25 | RBC CapitalBen Hendrix | $13 | 130.5% upside | |
| 2024-11-15 | Truist FinancialDavid MacDonald | $12 | 112.8% upside | |
| 2024-11-06 | Robert W. BairdEric Coldwell | $14 | 148.2% upside | |
| 2024-09-23 | Robert W. BairdEric Coldwell | $16 | 183.7% upside | |
| 2024-08-08 | UBSKevin Caliendo | $13 | 130.5% upside | |
| 2022-09-20 | Deutsche Bank | $28 | 396.5% upside | |
| 2022-09-19 | Truist Financial | $28 | 396.5% upside | |
| 2022-08-10 | RBC Capital | $29 | 414.2% upside | |
| 2022-08-10 | Leerink Partners | $29 | 414.2% upside | |
| 2022-07-26 | Truist FinancialDavid MacDonald | $24 | 325.5% upside | |